Sclérose en plaques associée à un syndrome des antiphospholipides : difficultés diagnostiques et thérapeutiques

Alarcon-Segovia, 1988, Primary antiphospholipid syndrome, J Rheumatol, 16, 482 Cervera, 1997, Chorea in the antiphospholipid syndrome. Clinical, radiologic and immunologic characteristics of 50 patients from our clinics and the recent literature, Medicine (Baltimore), 76, 203, 10.1097/00005792-199705000-00006 Chapman, 2004, The interface of multiple sclerosis and antiphospholipid antibodies, Thromb Res, 114, 477, 10.1016/j.thromres.2004.06.016 Collard, 1997, Frequency and significance of antinuclear antibodies in multiple sclerosis, Neurology, 49, 857, 10.1212/WNL.49.3.857 Cordoliani, 1998, Sclérose en plaques et anticorps antiphospholipides : étude consécutive de 62 patients, Rev Med Interne, 19, 635, 10.1016/S0248-8663(99)80042-3 Cuadrado, 2000, Can Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of literature, Medicine (Baltimore), 79, 57, 10.1097/00005792-200001000-00006 Członkowska, 2007, Multiple sclerosis and antiphospholipid syndrome-difficulties in differential diagnostics, Pol Arch Med Wewn, 117, 28 Ferreira, 2005, Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?, Rheumatology, 44, 434, 10.1093/rheumatology/keh532 Fukazawa, 1993, Anticardiolipin Antibodies in japanese patients with multiple sclerosis, Acta Neurol Scand, 88, 184, 10.1111/j.1600-0404.1993.tb04214.x Harada, 1995, Visual function in patients with optic neuritis associated with acute transverse myelopathy in multiple sclerosis, Jpn J Ophthalmol, 39, 290 Hughes, 2003, Migraine, memory loss, and “multiple sclerosis”. Neurological features of the antiphospholipid (Hughes’) syndrome, Postgraduate Med J, 79, 81, 10.1136/pmj.79.928.81 Vilisaar, 2005, A comparative audit of anticardiolipin antibodies in oligoclonal band Negative and positive multiple sclerosis, Mult Scler, 11, 378, 10.1191/1352458505ms1208oa Miyakis, 2006, International consensus statement on an update classification criterion for definite antiphospholipid syndrome (APS), J Thromb Haemost, 4, 295, 10.1111/j.1538-7836.2006.01753.x Roussel, 2000, Prevalence and clinical significance of antiphspholipid antibodies in multiple sclerosis: A study of 89 patients, J Autoimmun, 14, 259, 10.1006/jaut.2000.0367 Sastre Garriga, 2001, Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis, Ann Neurol, 49, 408, 10.1002/ana.81 Scott, 1994, Antiphospholipid antibody syndrome mimicking multiple sclerosis clinically and by magnetic resonance imaging, Arch Intern Med, 154, 917, 10.1001/archinte.1994.00420080127013 Siam, 1998, Multiple sclerosis-like picture in association with Hughes syndrome, Lupus, 7, 367, 10.1191/096120398678920235 Spirin NN, Pizova NV, Stepanov IO. Antiphospholipid syndrome and multiple sclerosis: differential-diagnostic aspects. Zh Nevrol Psikhiatr Im S S Korsakova 2002:42–5. Stosic, 2010, MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis, J Neurol, 257, 63, 10.1007/s00415-009-5264-6 Verrot, 1997, Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy, Am J Med, 103, 33, 10.1016/S0002-9343(97)90046-2